Olink and gut microbial metabolomics reveal new biomarkers for the prediction and diagnosis of PMOP
- 17 August 2024
- journal article
- review article
- Published by Springer Nature in Journal of Bone and Mineral Metabolism
- Vol. 42 (5) , 503-515
Abstract
Lntroduction Postmenopausal osteoporosis (PMOP) can cause postmenopausal women to experience pain and interference. Identifying and exploring potential early diagnostic biomarkers of PMOP is of substantial clinical value and social significance. This study aimed to screen for potential novel diagnostic biomarkers of PMOP through a multiomics approach, providing new directions and ideas for the early prevention and treatment of this disease. Materials and Methods Fifteen postmenopausal women with osteoporosis and 12 without were recruited. Clinical information was collected, and various clinical biochemical parameters were tested. Plasma and fecal samples were collected and analyzed using Olink proteomics and gut microbial metabolomics. Results The functions of the differentially abundant metabolites were mainly related to autophagy and arginine and proline metabolism and were involved in immunoinflammatory metabolic processes. Olink showed significant differences in the expression of seven inflammation-related proteins between the two groups. Conclusion We demonstrated that metabolic differences between PMOP patients and healthy controls were associated with inflammatory responses and found seven proteins with significant differences. Among these proteins, CDCP1, IL10, and IL-1alpha combined with clinical indicators had high discriminant efficiency in identifying PMOP. This is also the first study to demonstrate noteworthy changes in CDCP1 levels in patients with PMOP.Keywords
Funding Information
- National Natural Science Foundation of China (Grant No. 81973886)
- Key Plans of Hunan Administration Traditional Chinese Medicine Research Program Project (Grant No. A2024032)
- Clinical Medical Technology Innovation Guidance Project of Hunan (Grant No. 2021SK51306)
- Hunan Clinical Research Center of Bone Injury of Traditional Chinese Medicine, China (Grant No. 2020SK4013)
- Hunan University of Chinese Medicine Provincial discipline construction Project
This publication has 45 references indexed in Scilit:
- Sex Specific Global Burden of Osteoporosis in 204 Countries and Territories, from 1990 to 2030: An Age-Period-Cohort Modeling StudyThe Journal of nutrition, health and aging, 2023
- Metastatic prostate cancer‐derived extracellular vesicles facilitate osteoclastogenesis by transferring the CDCP1 proteinJournal of Extracellular Vesicles, 2023
- The Effects of Osteoporotic and Non-osteoporotic Medications on Fracture Risk and Bone Mineral DensityDrugs, 2021
- Targeting immune dysfunction in agingAgeing Research Reviews, 2021
- Extracellular Vesicles from Child Gut Microbiota Enter into Bone to Preserve Bone Mass and StrengthAdvanced Science, 2021
- Increased immunosuppression impairs tissue homeostasis with aging and age-related diseasesJournal of Molecular Medicine, 2020
- The epidemiology of osteoporosis, associated fragility fractures, and management gap in ChinaArchives of Osteoporosis, 2019
- The epidemiology of osteoporosis in Italian postmenopausal women according to the National Bone Health Alliance (NBHA) diagnostic criteria: a multicenter cohort studyJournal of Endocrinological Investigation, 2017
- Mast Cells Are Critical Regulators of Bone Fracture–Induced Inflammation and Osteoclast Formation and ActivityJournal of Bone and Mineral Research, 2017
- Relationship of circulating MMP–2, MMP–1, and TIMP–1 levels with bone biochemical markers and bone mineral density in postmenopausal Chinese womenOsteoporosis International, 2005